| Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis N Pernigoni, E Zagato, A Calcinotto, M Troiani, RP Mestre, B Calì, ... Science 374 (6564), 216-224, 2021 | 163 | 2021 |
| Senescence reprogramming by TIMP1 deficiency promotes prostate cancer metastasis I Guccini, A Revandkar, M D'Ambrosio, M Colucci, E Pasquini, S Mosole, ... Cancer cell 39 (1), 68-82. e9, 2021 | 88 | 2021 |
| Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer M Troiani, M Colucci, M D’Ambrosio, I Guccini, E Pasquini, A Varesi, ... Nature communications 13 (1), 2177, 2022 | 49 | 2022 |
| Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer N Bancaro, B Calì, M Troiani, AR Elia, RA Arzola, G Attanasio, P Lai, ... Cancer cell 41 (3), 602-619. e11, 2023 | 36 | 2023 |
| HER3 is an actionable target in advanced prostate cancer V Gil, S Miranda, R Riisnaes, B Gurel, M D’Ambrosio, A Vasciaveo, ... Cancer research 81 (24), 6207-6218, 2021 | 31 | 2021 |
| CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo A Alajati, M D’Ambrosio, M Troiani, S Mosole, L Pellegrini, J Chen, ... The Journal of clinical investigation 130 (5), 2435-2450, 2020 | 31 | 2020 |
| Retinoic acid sensitivity of triple-negative breast cancer cells characterized by constitutive activation of the notch1 pathway: the role of Rarβ G Paroni, A Zanetti, MM Barzago, M Kurosaki, L Guarrera, M Fratelli, ... Cancers 12 (10), 3027, 2020 | 12 | 2020 |
| The potential role of the microbiota in prostate cancer pathogenesis and treatment N Pernigoni, C Guo, L Gallagher, W Yuan, M Colucci, M Troiani, L Liu, ... Nature Reviews Urology 20 (12), 706-718, 2023 | 8 | 2023 |
| The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells D Brina, A Ponzoni, M Troiani, B Calì, E Pasquini, G Attanasio, S Mosole, ... Nature Cancer 4 (8), 1102-1121, 2023 | 6 | 2023 |
| VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer R Alvarez-Arzola, N Bancaro, P Lai, G Attanasio, L Pellegrini, M Troiani, ... Cell Communication and Signaling 21 (1), 76, 2023 | 3 | 2023 |
| Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells M Colucci, S Zumerle, S Bressan, F Gianfanti, M Troiani, A Valdata, ... Cancer Cell, 2024 | 1 | 2024 |
| Author Correction: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer M Troiani, M Colucci, M D’Ambrosio, I Guccini, E Pasquini, A Varesi, ... nature communications 14, 2023 | 1 | 2023 |
| VSSP-treated macrophages reduce tumor growth in mice with castration-resistant prostate cancer R Alvarez-Arzola, N Bancaro, P Lai, G Attanasio, L Pellegrini, M Troiani, ... | | 2023 |
| Mitochondrial DNA released by senescent cells triggers immunosuppression in cancer P Lai, L Liu, N Bancaro, M Troiani, B Cali, J Chen, PK Singh, RA Arzola, ... bioRxiv, 2023.08. 06.551763, 2023 | | 2023 |
| HER3 is an actionable target in advanced prostate cancer S Miranda, V Gil, R Riisnaes, B Gurel, M D’Ambrosio, A Vasciaveo, ... Cancer Research 82 (12_Supplement), 2807-2807, 2022 | | 2022 |
| ApoE-TREM2 axis induces pathogenic senescent-like myeloid cells in prostate cancer A Calcinotto, N Bancaro, M Troiani, R Arzola, AR Elia, G Attanasio, B Calì, ... | | 2021 |
| Abstract LB-005: Senescence reprogramming in primary tumors initiates prostate cancer metastases I Guccini, A Revandkar, M D'Ambrosio, M Colucci, E Pasquini, S Mosole, ... Cancer Research 80 (16_Supplement), LB-005-LB-005, 2020 | | 2020 |
| Abstract P5-05-08: Molecular cross-talk between retinoic acid and NOTCH1 signaling pathways: Role in triple negative breast cancer G Paroni, A Zanetti, M Bolis, A Vallerga, M Troiani, M Fratelli, M Kurosaki, ... Cancer Research 79 (4_Supplement), P5-05-08-P5-05-08, 2019 | | 2019 |
